- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04117737
A Pilot Study of Virtual Reality and Antigravity Treadmill for Gait Improvement in Parkinson
Effects of Virtual Reality Combined With Antigravity Treadmill Rehabilitation for Gait Improvement of Patients With Parkinson's Disease: a Pilot Study
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Zaragoza, Spain, 50015
- Asociación de Parkinson de Aragón
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Having Parkinson's disease diagnosed by a neurological doctor.
- Having an alteration of the gait caused by the neurological disorder.
- Being able to have an independent and voluntary walk of 10 meters as minimum.
- Height more than 150 cm.
Exclusion Criteria:
- Being blind.
- Medical contraindications for walking.
- Being amputee.
- Alcohol or drugs abuse.
- Other diseases that impedes the intervention.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention
Single-arm
|
The system is composed of three major parts: the treadmill, the antigravity system and the virtual reality system. The treadmill is the base of the device. It is a rounded and concave structure that permits to walk in all direction. For simulate anti-gravity, a harness and pulley system allow to regulate the weight. Finally, the virtual reality system enables participants to simulate an experience of daily life. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in gait autonomy
Time Frame: Baseline and 4-weeks
|
Changes in gait autonomy will be measured by 6-Minutes Walking Test (6MWT).
The 6MWT consists of measuring the maximum distance (in meters) that the subject can walk during 6 minutes in a flat surface.
|
Baseline and 4-weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in gait speed
Time Frame: Baseline and 4-weeks
|
Changes in gait speed will be measured by 10-Meter Walk Test (10MWT).
The 10MWT consists of asking the subject to walk a 14m distance on flat area and measure the time spent from meter 2 to meter 12.
Time will be measured by a digital chronometer.
Gait speed will be calculated in meter per second.
|
Baseline and 4-weeks
|
|
Changes in balance and gait ability
Time Frame: Baseline and 4-weeks
|
Changes in balance and gait ability will be measured by Tinetti scale.
The Tinetti test is a simple, reproducible way of assessing the risk of falling in the elderly.
This scale is composed of two value, static and dynamic: the test grants a maximum of 16 points for static part (sitting) and 12 point for dynamic (walking) part.
Higher is the score, better is the performance.
|
Baseline and 4-weeks
|
|
Changes in quality of life
Time Frame: Baseline and 4-weeks
|
Changes in quality of life will be measured by by 36-Item Short-Form Health Survey (SF-36).
SF-36 assesses 8 physical and mental health domains: 1) Physical Functioning, 2) Social Functioning, 3) Role-Physical, 4) Bodily Pain, 5) Mental Health), 6) Role-Emotional, 7) Vitality, and 8) General Health.
For each scale, item scores are coded, summed, and transformed, with final values expressed as a percentage, ranging from 0 (worst health) to 100 (best health).
|
Baseline and 4-weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Pablo Herrero, PhD, Universidad San Jorge
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PI18/386
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson Disease
-
Bezmialem Vakif UniversityRecruitingParkinson Disease | Parkinson | Parkinson Disease (PD) | PARKINSON DISEASE (Disorder) | Parkinson s DiseaseTurkey (Türkiye)
-
CND Life SciencesDigestive Disease Associates of CTRecruitingParkinson Disease | Parkinson | PARKINSON DISEASE (Disorder) | Parkinson s DiseaseUnited States
-
Neuron23 Inc.Roche Diagnostic Ltd.; Qiagen Manchester LimitedRecruitingParkinson Disease | Parkinson | Idiopathic Parkinson Disease | Parkinson Disease, Idiopathic | Early Parkinson Disease (Early PD)United States, Spain, Israel, Poland, Italy, United Kingdom
-
San Francisco Neurology and Sleep CenterNot yet recruitingPARKINSON DISEASE (Disorder) | Parkinson s DiseaseUnited States
-
Haukeland University HospitalUniversity of Bergen; SPARK NSRecruitingParkinson Disease (PD) | Parkinson s DiseaseNorway
-
CND Life SciencesOregon Health and Science UniversityRecruitingParkinson Disease | Parkinson | Parkinson's Disease and Parkinsonism | PARKINSON DISEASE (Disorder)United States
-
Università degli Studi dell'InsubriaUniversidade Nova de Lisboa; Associazione Parkinson Insubria (AsPI), Section... and other collaboratorsRecruitingParkinson Disease | Parkinson | Parkinson Disease, Idiopathic | PARKINSON DISEASE (Disorder)Italy
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedParkinson Disease 6, Early-Onset | Parkinson Disease (Autosomal Recessive, Early Onset) 7, Human | Parkinson Disease Autosomal Recessive, Early Onset | Parkinson Disease, Autosomal Recessive Early-Onset, Digenic, Pink1/Dj1United States
-
Duke UniversityMedical University of South Carolina; Massachusetts General Hospital; Mayo Clinic and other collaboratorsNot yet recruitingGut Microbiota | Gut Microbiome | Parkinson Disease (PD) | PARKINSON DISEASE (Disorder) | Prodromal Parkinsons DiseaseUnited States
-
ProgenaBiomeWithdrawnParkinson Disease | Parkinsons Disease With Dementia | Parkinson-Dementia Syndrome | Parkinson Disease 2 | Parkinson Disease 3 | Parkinson Disease 4United States
Clinical Trials on Virtual reality combined with anti-gravity treadmill
-
Somogy Megyei Kaposi Mór Teaching HospitalRecruiting
-
Riphah International UniversityRecruitingFall | Old AgePakistan
-
University of Vic - Central University of CataloniaNot yet recruitingCerebral Palsy, SpasticSpain
-
Universitat de LleidaUniversity of Maryland, Baltimore; University of TurkuRecruiting
-
Orton Orthopaedic HospitalCompleted
-
Tel-Aviv Sourasky Medical CenterCompletedMultiple SclerosisIsrael, United States
-
Shirley Ryan AbilityLabUnknownKnee OsteoarthritisUnited States
-
University Medicine GreifswaldCompletedHealthy VolunteersGermany
-
Qassim UniversityCompleted
-
University of LeipzigCompletedRehabilitation | Weight-bearing